Deerfield Management Company, L.P. (Series C) Cerus Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Cerus Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 44,693 shares of CERS stock, worth $61,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,693
Previous 50,305
11.16%
Holding current value
$61,676
Previous $77,000
19.48%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CERS
# of Institutions
167Shares Held
149MCall Options Held
24.2KPut Options Held
44.4K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl20.7MShares$28.5 Million0.31% of portfolio
-
Baker Bros. Advisors LP New York, NY19.4MShares$26.7 Million0.32% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$19.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$14.6 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.32MShares$11.5 Million0.07% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $244M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...